Leaflet: information for the user
BUCOSIL 5mg/5mg Orange Flavored Lozenges
Chlorhexidine Dihydrochloride/Benzocaine
Read the entire leaflet carefully before starting to use this medication, as it contains important information for you
Follow the administration instructions of the medication contained in this leaflet or as indicated by your doctor or pharmacist exactly.
Contents of the leaflet:
Chlorhexidine and benzocaine, the active ingredients of this medication, act by combining the antiseptic and disinfectant action of chlorhexidine with the local anesthetic action of benzocaine.
This medication is indicated for the symptomatic and temporary relief of mild infectious processes of the mouth and throat, such as oral aphthae and throat irritation, which occur with pain and without fever in adults and children from 6 years of age.
You should consult a doctor if it worsens or does not improve after 2 days.
Consult your doctor or pharmacist before starting to use BUCOSIL:
Maintain good oral hygiene to reduce the accumulation of tartar and possible tooth discoloration that may be caused by chlorhexidine.
Interference with analytical tests
If you are going to undergo any diagnostic test (including blood tests, urine tests, skin tests that use allergens, etc.), inform your doctor that you are using this medication, as it may alter the results.
This medication may interact with pancreatic function tests that use bentiromide. Do not use this medication at least 3 days before the test and inform your doctor.
Children
This medication should not be used in children under 6 years of age.
Between 6 and 12 years, children can only use it under adult supervision.
Use in people over 65 years of age
People over 65 years of age and debilitated patients may be more sensitive to benzocaine.
Other medications and BUCOSIL
Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.
This is especially important in the case of:
Anionic compounds and suspending agents (common components of toothpastes) reduce the effectiveness of chlorhexidine, so the mouth should be rinsed well after using toothpaste.
Using BUCOSIL with food and drinks
This medication cannot be used immediately before eating or drinking.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Driving and using machines
No effects on the ability to drive or use machines have been described.
BUCOSIL contains glucose
This medication contains glucose (in maltodextrin from potato and corn). If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication. It may cause cavities.
Follow the administration instructions of the medication contained in this leaflet or as indicated by your doctor or pharmacist exactly. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is:
Adults and children over 6 years:Dissolve slowly in the mouth 1 lozenge every 2 or 3 hours, if necessary, up to a maximum of 8 lozenges per day.
Use in children
This medication should not be used in children under 6 years of age.
Between 6 and 12 years, children can only use it under adult supervision.
Elderly patients
People over 65 years of age and debilitated patients should consult their doctor, as they may be more sensitive to the effects of benzocaine.
The recommended dose is:
BUCOSIL is a medication for buccopharyngeal use, so the lozenges should be dissolved slowly in the mouth without chewing or swallowing, as its action is local and only manifests when the product is in direct contact with the affected area.
You should consult a doctor if it worsens or does not improve after 2 days of treatment.
If you notice that after 2 days of starting treatment you have a fever, headache, nausea, or vomiting, you should consult your doctor as soon as possible.
If you take more BUCOSIL than you should
Signs of overdose are: slurred speech, numbness, staggering gait, blurred or double vision, dizziness, excitement or convulsions, ringing in the ears, increased sweating, and/or low blood pressure.
In case of overdose or accidental ingestion, go immediately to a medical center or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
Like all medications, this medication can cause side effects, although not everyone experiences them.
The side effects that may occur, whose frequency has not been determined with precision, are:
Possible tooth discoloration. This pigmentation or discoloration can occur especially in people who have tartar buildup. This alteration of tooth color is not permanent and can be eliminated through a dental cleaning. The color of fillings can also be altered, in which case this discoloration can be permanent.
Some people may develop alterations in taste perception.
In some cases, BUCOSIL can cause irritation in the mouth or on the tip of the tongue, which are usually transient, as well as allergic reactions to chlorhexidine or benzocaine.
Reporting side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use www.notificaRAM.es.
By reporting side effects, you can contribute to providing more information on the safety of this medication.
Do not store at a temperature above 30°C.
Do not use this medication after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be thrown down the drain or into the trash. Deposit the packaging and medications you no longer need in the SIGRE point of your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This way, you will help protect the environment.
.
Appearance of the product and package contents:
They are orange-flavored lozenges. This medication is presented in packages of 20 lozenges packaged in aluminum blisters coated with PVDC and layered with PVC/PE/PVDC.
Marketing authorization holder:
Medical, S.A.
Pol. Ind. Las Quemadas, Parcela 87
14014 - Córdoba
Manufacturer:
Laboratorios Alcalá Farma, S.L.
Avenida de Madrid, 82
28802 Alcalá de Henares (Madrid)
Date of the last revision of this leaflet: September 2020
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/